Q-linea’s mission is to improve sepsis treatment and to safeguard effectiveness of antibiotics for coming generations. ASTar® is our CE-IVD marked and FDA 510(k) cleared system for automated rapid testing of antibiotic susceptibility, delivering actionable results for critically ill patients in ~6 hours compared to up to 48 hours for current standard of care. Q-linea AB is represented in Europe, USA and the Middle East with a growing commercial footprint.